Report Detail
Global TDS(Transdermal Delivery Systems) Market Opportunities and Forecast 2022-2028
- RnM4417490 |
- 04 April, 2022 |
- Global |
- 164 Pages |
- GRD Survey |
- Pharma & Healthcare
This report provides a comprehensive analysis of current global TDS(Transdermal Delivery Systems) market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the TDS(Transdermal Delivery Systems) industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to GRD Survey, the global TDS(Transdermal Delivery Systems) market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global TDS(Transdermal Delivery Systems) Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global TDS(Transdermal Delivery Systems) market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global TDS(Transdermal Delivery Systems) Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global TDS(Transdermal Delivery Systems) industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Segmented by Application
Hospital
Clinic
Other
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Tesa Labtec
Teikoku Seiyaku
Sorrento Therapeutics
Pfizer
Mylan
IBSA Group
Hisamitsu
Harro Hofliger
Endo International
Adhex Pharma
Table of Contents
1 Product Introduction and Overview
- 1.1 Product Definition
- 1.2 Product Specification
- 1.3 Global Market Overview
- 1.3.1 Global TDS(Transdermal Delivery Systems) Market Status and Forecast (2017-2028)
- 1.3.2 Global TDS(Transdermal Delivery Systems) Sales Value CAGR by Region
- 1.4 Market Drivers, Inhibitors
- 1.4.1 Market Drivers
- 1.4.2 Market Inhibitors
- 1.4.3 COVID-19 Impact Analysis
2 Global TDS(Transdermal Delivery Systems) Supply by Company
- 2.1 Global TDS(Transdermal Delivery Systems) Sales Volume by Company
- 2.2 Global TDS(Transdermal Delivery Systems) Sales Value by Company
- 2.3 Global TDS(Transdermal Delivery Systems) Price by Company
- 2.4 TDS(Transdermal Delivery Systems) Production Location and Sales Area of Main Manufacturers
- 2.5 Trend of Concentration Rate
3 Global and Regional TDS(Transdermal Delivery Systems) Market Status by Type
- 3.1 TDS(Transdermal Delivery Systems) Type Introduction
- 3.1.1 Single-layer Drug-in-Adhesive
- 3.1.2 Multi-layer Drug-in-Adhesive
- 3.1.3 Others
- 3.2 Global TDS(Transdermal Delivery Systems) Market by Type
- 3.2.1 Global TDS(Transdermal Delivery Systems) Sales Volume by Type (2017-2022)
- 3.2.2 Global TDS(Transdermal Delivery Systems) Sales Value by Type (2017-2022)
- 3.2.3 Global TDS(Transdermal Delivery Systems) Price by Type (2017-2022)
- 3.3 North America: by Type
- 3.4 Europe: by Type
- 3.5 Asia Pacific: by Type
- 3.6 Central & South America: by Type
- 3.7 Middle East & Africa: by Type
4 Global and Regional TDS(Transdermal Delivery Systems) Market Status by Application
- 4.1 TDS(Transdermal Delivery Systems) Segment by Application
- 4.1.1 Hospital
- 4.1.2 Clinic
- 4.1.3 Other
- 4.2 Global TDS(Transdermal Delivery Systems) Market by Application
- 4.2.1 Global TDS(Transdermal Delivery Systems) Sales Volume by Application (2017-2022)
- 4.2.2 Global TDS(Transdermal Delivery Systems) Sales Value by Application (2017-2022)
- 4.2.3 Global TDS(Transdermal Delivery Systems) Price by Application (2017-2022)
- 4.3 North America: by Application
- 4.4 Europe: by Application
- 4.5 Asia Pacific: by Application
- 4.6 Central & South America: by Application
- 4.7 Middle East & Africa: by Application
5 Global TDS(Transdermal Delivery Systems) Market Status by Region
- 5.1 Global TDS(Transdermal Delivery Systems) Market by Region
- 5.1.1 Global TDS(Transdermal Delivery Systems) Sales Volume by Region
- 5.1.2 Global TDS(Transdermal Delivery Systems) Sales Value by Region
- 5.2 North America TDS(Transdermal Delivery Systems) Market Status
- 5.3 Europe TDS(Transdermal Delivery Systems) Market Status
- 5.4 Asia Pacific TDS(Transdermal Delivery Systems) Market Status
- 5.5 Central & South America TDS(Transdermal Delivery Systems) Market Status
- 5.6 Middle East & Africa TDS(Transdermal Delivery Systems) Market Status
6 North America TDS(Transdermal Delivery Systems) Market Status
- 6.1 North America TDS(Transdermal Delivery Systems) Market by Country
- 6.1.1 North America TDS(Transdermal Delivery Systems) Sales Volume by Country (2017-2022)
- 6.1.2 North America TDS(Transdermal Delivery Systems) Sales Value by Country (2017-2022)
- 6.2 United States
- 6.3 Canada
- 6.4 Mexico
7 Europe TDS(Transdermal Delivery Systems) Market Status
- 7.1 Europe TDS(Transdermal Delivery Systems) Market by Country
- 7.1.1 Europe TDS(Transdermal Delivery Systems) Sales Volume by Country (2017-2022)
- 7.1.2 Europe TDS(Transdermal Delivery Systems) Sales Value by Country (2017-2022)
- 7.2 Germany
- 7.3 France
- 7.4 UK
- 7.5 Italy
- 7.6 Russia
- 7.7 Spain
8 Asia Pacific TDS(Transdermal Delivery Systems) Market Status
- 8.1 Asia Pacific TDS(Transdermal Delivery Systems) Market by Country
- 8.1.1 Asia Pacific TDS(Transdermal Delivery Systems) Sales Volume by Country (2017-2022)
- 8.1.2 Asia Pacific TDS(Transdermal Delivery Systems) Sales Value by Country (2017-2022)
- 8.2 China
- 8.3 Japan
- 8.4 Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australasia
9 Central & South America TDS(Transdermal Delivery Systems) Market Status
- 9.1 Central & South America TDS(Transdermal Delivery Systems) Market by Country
- 9.1.1 Central & South America TDS(Transdermal Delivery Systems) Sales Volume by Country (2017-2022)
- 9.1.2 Central & South America TDS(Transdermal Delivery Systems) Sales Value by Country (2017-2022)
- 9.2 Brazil
- 9.3 Argentina
- 9.4 Colombia
10 Middle East & Africa TDS(Transdermal Delivery Systems) Market Status
- 10.1 Middle East & Africa TDS(Transdermal Delivery Systems) Market by Country
- 10.1.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales Volume by Country (2017-2022)
- 10.1.2 Middle East & Africa TDS(Transdermal Delivery Systems) Sales Value by Country (2017-2022)
- 10.2 Iran
- 10.3 Israel
- 10.4 Turkey
- 10.5 South Africa
- 10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
- 11.1 Supply Chain Analysis
- 11.2 Production Process Chart Analysis
- 11.3 Raw Materials and Key Suppliers Analysis
- 11.3.1 Raw Materials Introduction
- 11.3.2 Raw Materials Key Suppliers List
- 11.4 TDS(Transdermal Delivery Systems) Manufacturing Cost Analysis
- 11.5 TDS(Transdermal Delivery Systems) Sales Channel and Distributors Analysis
- 11.5.1 TDS(Transdermal Delivery Systems) Sales Channel
- 11.5.2 TDS(Transdermal Delivery Systems) Distributors
- 11.6 TDS(Transdermal Delivery Systems) Downstream Major Buyers
12 Global TDS(Transdermal Delivery Systems) Market Forecast by Type and by Application
- 12.1 Global TDS(Transdermal Delivery Systems) Sales Volume and Sales Value Forecast (2023-2028)
- 12.2 Global TDS(Transdermal Delivery Systems) Forecast by Type
- 12.2.1 Global TDS(Transdermal Delivery Systems) Sales Volume Forecast by Type
- 12.2.2 Global TDS(Transdermal Delivery Systems) Sales Value Forecast by Type
- 12.2.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Type
- 12.3 Global TDS(Transdermal Delivery Systems) Forecast by Application
- 12.3.1 Global TDS(Transdermal Delivery Systems) Sales Volume Forecast by Application
- 12.3.2 Global TDS(Transdermal Delivery Systems) Sales Value Forecast by Application
- 12.3.3 Global TDS(Transdermal Delivery Systems) Price Forecast by Application
13 Global TDS(Transdermal Delivery Systems) Market Forecast by Region/Country
- 13.1 Global TDS(Transdermal Delivery Systems) Market Forecast by Region (2023-2028)
- 13.1.1 Global TDS(Transdermal Delivery Systems) Sales Volume Forecast by Region (2023-2028)
- 13.1.2 Global TDS(Transdermal Delivery Systems) Sales Value Forecast by Region (2023-2028)
- 13.2 North America Market Forecast
- 13.3 Europe Market Forecast
- 13.4 Asia Pacific Market Forecast
- 13.5 Central & South America Market Forecast
- 13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
- 14.1 Toyochem
- 14.1.1 Company Information
- 14.1.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.1.3 Toyochem TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.1.4 SWOT Analysis
- 14.2 Teva Pharmaceutical
- 14.2.1 Company Information
- 14.2.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.2.3 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.2.4 SWOT Analysis
- 14.3 Tesa Labtec
- 14.3.1 Company Information
- 14.3.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.3.3 Tesa Labtec TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.3.4 SWOT Analysis
- 14.4 Teikoku Seiyaku
- 14.4.1 Company Information
- 14.4.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.4.3 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.4.4 SWOT Analysis
- 14.5 Sorrento Therapeutics
- 14.5.1 Company Information
- 14.5.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.5.3 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.5.4 SWOT Analysis
- 14.6 Pfizer
- 14.6.1 Company Information
- 14.6.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.6.3 Pfizer TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.6.4 SWOT Analysis
- 14.7 Mylan
- 14.7.1 Company Information
- 14.7.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.7.3 Mylan TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.7.4 SWOT Analysis
- 14.8 IBSA Group
- 14.8.1 Company Information
- 14.8.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.8.3 IBSA Group TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.8.4 SWOT Analysis
- 14.9 Hisamitsu
- 14.9.1 Company Information
- 14.9.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.9.3 Hisamitsu TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.9.4 SWOT Analysis
- 14.10 Harro Hofliger
- 14.10.1 Company Information
- 14.10.2 TDS(Transdermal Delivery Systems) Product Introduction
- 14.10.3 Harro Hofliger TDS(Transdermal Delivery Systems) Sales Volume, Price, Sales Value and Gross Margin (2020-2022)
- 14.10.4 SWOT Analysis
- 14.11 Endo International
- 14.12 Adhex Pharma
15 Conclusion
16 Methodology
Summary:
Get latest Market Research Reports on TDS(Transdermal Delivery Systems). Industry analysis & Market Report on TDS(Transdermal Delivery Systems) is a syndicated market report, published as Global TDS(Transdermal Delivery Systems) Market Opportunities and Forecast 2022-2028. It is complete Research Study and Industry Analysis of TDS(Transdermal Delivery Systems) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
